SCHEMBL1950586

SCHEMBL1950586

O=C1COc2ncccc2CN1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43
CA12 O43570 2/20 0.35
CA9 Q16790 2/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
PDE1A P54750 5/20 0.34
PDE1B Q01064 5/20 0.34
PDE1C Q14123 5/20 0.34
MAOB P27338 2/20 0.32
MAOA P21397 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
PARP1 P09874 1/20 0.31
P2RX7 Q99572 2/20 0.31
TIPARP Q7Z3E1 1/20 0.31
AKR1B1 P15121 1/20 0.31
NR3C2 P08235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18796247 0.75 CA12 (0.37) CA12CA9CA1CA2PARP1
SCHEMBL9025634 0.74 ALDH1A1 (0.59) ALDH1A1AKR1C3AKR1C2AKR1C1CA12
SCHEMBL279914 0.74 CYP11B1 (0.44) CYP11B1CYP11B2PARP1NR3C2SMN1; SMN2
SCHEMBL29561576 0.74 CYP11B1 (0.44) CYP11B1CYP11B2PARP1NR3C2SMN1; SMN2
Hydrochloric Acid SCHEMBL30693477 0.72 CYP11B1 (0.43) CYP11B1CYP11B2PARP1NR3C2SMN1; SMN2
SCHEMBL31111396 0.70 SSTR4 (0.40) PDE1APDE1BPDE1CMAOBSMN1; SMN2
SCHEMBL10199987 0.70 SSTR4 (0.40) PDE1APDE1BPDE1CMAOBSMN1; SMN2
SCHEMBL1253734 0.69 CA12 (0.38) ALDH1A1AKR1C3AKR1C2AKR1C1CA12
SCHEMBL299664 0.69 PDE3B (0.41) ALDH1A1AKR1C3AKR1C2AKR1C1CA12
Hydrochloric Acid SCHEMBL2110952 0.69 SSTR4 (0.39) ALDH1A1PDE1APDE1BPDE1CMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130281435-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME TAKEDA PHARMACEUTICAL COMPANY LIMITED 2013-10-24 US disclosed
US-20110136788-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136788-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME GPBAR1, GPR35, GRPR ALDH1A1 2996/4885AKR1C3 792/4885AKR1C2 697/4885
US-20130281435-A1 THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME GPBAR1, GPR35, GRPR ALDH1A1 3137/4885AKR1C3 797/4885AKR1C2 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.